Anti-emetics and cancer chemotherapy
1990
Understanding Anti-emetics in Cancer Chemotherapy
Editorial
Author Information
Author(s): R.C.F. Leonard, M. Soukop
Conclusion
Recent developments in anti-emetics show promise in significantly reducing nausea and vomiting caused by cancer chemotherapy.
Supporting Evidence
- High-dose metoclopramide has shown dramatic effects against cisplatinum-induced vomiting.
- 5HT3 receptor antagonists have an excellent side-effect profile and provide significant protection from emesis.
- Combination therapies with corticosteroids and benzodiazepines may enhance anti-emetic control.
Takeaway
This article talks about how doctors are finding better ways to help cancer patients not feel sick from their medicine. They are using new medicines and combinations to make patients feel better.
Want to read the original?
Access the complete publication on the publisher's website